In year 2015, Beike was elected in China National 863 Key Project for Individualized Cells therapy using allogenic stem cells. The 863 program or State High-Tech Development was a program funded and administered by the government of the People’s Republic of China intended to stimulate the development of advanced technologies in a wide range of fields for the purpose of rendering China independent of financial obligations for foreign technologies.

Our honorable 863 program

Transfusion Institute of the Military Academy of Sciences (863 Program “Clinical Transformation and Application Development of Stem Cell Medical Technology”)
PLA Navy General Hospital (863 Program “Multi-center clinical trial of stem cells for myocardial infarction”